A lot of them saw their body weight come down by a lot
Combining with DPP-4 inhibitors is generally not recommended, as both drug classes work on the incretin system Adding basal insulin for those with more significant hyperglycaemia, which can be used alongside GLP-1 medications (with careful monitoring for hypoglycaemia) Switching to insulin therapy entirely may be necessary for those with advanced beta cell failure For weight management , when GLP-1 medications don't produce adequate weight loss, alternatives include: Orlistat , a lipase inhibitor that reduces fat absorption, though weight loss is typically modest (2-3 kg on average) Naltrexone-bupropion (Mysimba), which works on appetite centres through different pathways
They also slow gastric emptying (the speed at which food moves from the stomach into the small intestine), helping stabilize blood sugar and further maintaining feelings of fullness
Constantino A
Retatrutide is an investigational triple receptor agonist currently undergoing clinical trials
Regulatory review for additional oral GLP-1 options is anticipated in the coming years, potentially as early as 2026